See May's 10 most-read stories, from how companies are coming out with new immune-related supplements for general health or as an adjunctive to COVID-19 treatment, to new omega-3 regulations in South Korea, efforts around sustainability and more.
MGC Pharma is working on introducing its product that has shown to speed up recovery in COVID-19 patients, as a natural health or ayurvedic product in several Asian countries, including India, Malaysia, Myanmar, and Thailand.
The absence of micronutrient deficiency, such as vitamin D, has shown to reduce the incidence of COVID-19, as well as lowering the odds of clinical deterioration in COVID-19 patients, said the findings of a systematic review and meta-analysis.
ASX-listed company Jatcorp has developed a line-up of five new immune-supporting powder formula which is due to launch in the second half of this year in China and Australia.
H&H Group is pushing for the use of sustainable packaging, including recyclable, renewable, compostable materials, across its brands, including Swisse, Good Goût, CBII and its infant formula range.
The South Korean authorities have released a proposal on how oxidation should be measured in EPA and DHA products, in what is being seen as a move to bridge the gap between locally-made and imported products.
BioGaia is launching its bone health probiotic, Osfortis, into China via cross-border e-commerce (CBEC) channel – its first Asian market for the product.
Chilean astaxanthin producer Atacama Bio Natural Products S.A has entered into an exclusive distribution partnership with Malaysia-based Nexus Wise to distribute its branded astaxanthin ingredients in Malaysia and Singapore.
The supplementation of electrolytes could potentially reduce the incidence of muscle cramps due to different factors, including exercise, ageing, and pregnancy, according to the latest guest on our NutraChampion podcast, Professor Ken Nosaka.
ASX-listed company Holista Colltech has outlined its new product launch, with an omega-3 gummy for kids and vitamin D drops in the pipeline.
India is offering a wealth of opportunities for nutrition brands in Australia and beyond, as consumer demand continues to rise and efforts to remove trade obstacles progress, according to Pharmako Biotechnologies, which has been named SME of the Year in the India Australia Business & Community Awards.